Announce Date | 02/26/2025 |
EPS Normalized Actual | $0.51 (Miss by $-0.01) |
EPS GAAP Actual | $0.51 (Miss by $-0.01) |
Revenue Actual | $1.861B |
Revenue Surprise | Beat by $1861M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 2.4552 | 14.17 | 2.41885 | 2.48611 | 1 |
Dec 2026 | 2.46923 | 14.09 | 2.43267 | 2.50032 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.24 | 0.24 | 1.861B | 5.48% | 1861M |
FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 1.826B | 2.3% | 1826M |
FQ1 2019 (Mar 2019) | 0.0491 | 0.0491 | 0.922B | 100% | 922M |
FQ2 2024 (Jun 2024) | 0.25 | 0.25 | 1.73B | -2.37% | 1730M |
FQ1 2024 (Mar 2024) | -1.34 | -1.34 | 1.601B | -0.81% | 1601M |
FQ4 2023 (Dec 2023) | 0.11 | 0.11 | 1.759B | 3.18% | 1759M |
FQ3 2023 (Sep 2023) | 0.18 | 0.18 | 1.784B | 2.75% | 1784M |
FQ2 2001 (Jun 2001) | 0 | 0 | 1.146B | 100% | 1146M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0.7169 | -- | 0.7129 | 0.72243 | 0 |
FQ3 2027 (Jul 2027) | 0.6257 | -- | 0.62221 | 0.63052 | 0 |
FQ2 2027 (Jun 2027) | 0.6257 | -- | 0.61824 | 0.63403 | 2 |
FQ1 2027 (Mar 2027) | 0.4386 | -- | 0.4386 | 0.4386 | 2 |
FQ4 2026 (Oct 2026) | 0.67168 | -- | 0.66794 | 0.67686 | 0 |
FQ3 2026 (Jul 2026) | 0.60083 | -- | 0.59748 | 0.60546 | 0 |
FQ2 2026 (Jun 2026) | 0.6257 | -- | 0.61824 | 0.63403 | 3 |
FQ1 2026 (Mar 2026) | 0.47544 | -- | 0.47544 | 0.47544 | 2 |
FQ4 2025 (Oct 2025) | 0.61167 | 60.76 | 0.60826 | 0.61639 | 1 |
FQ3 2025 (Sep 2025) | 0.62628 | 60.08 | 0.61881 | 0.63462 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.08B | -- | 2.07B | 2.09B | 0 |
FQ3 2027 (Jul 2027) | 2.01B | -- | 2B | 2.02B | 0 |
FQ2 2027 (Jun 2027) | 2.01B | -- | 1.99B | 2.03B | 2 |
FQ1 2027 (Mar 2027) | 1.76B | -- | 1.76B | 1.76B | 4 |
FQ4 2026 (Oct 2026) | 2.06B | -- | 2.05B | 2.07B | 0 |
FQ3 2026 (Jul 2026) | 1.97B | -- | 1.96B | 1.98B | 0 |
FQ2 2026 (Jun 2026) | 2.01B | -- | 1.99B | 2.03B | 2 |
FQ1 2026 (Mar 2026) | 1.83B | -- | 1.83B | 1.83B | 4 |
FQ4 2025 (Oct 2025) | 2B | 6.78 | 1.99B | 2.01B | 0 |
FQ3 2025 (Sep 2025) | 1.98B | 7.86 | 1.96B | 2B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.24 | 0.24 | 100% | |
FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 100% | |
FQ1 2019 (Mar 2019) | 0.0491 | 0.0491 | 100% | |
FQ2 2024 (Jun 2024) | 0.25 | 0.25 | 100% | |
FQ1 2024 (Mar 2024) | -1.34 | -1.34 | 100% | |
FQ4 2023 (Dec 2023) | 0.11 | 0.11 | 100% | |
FQ3 2023 (Sep 2023) | 0.18 | 0.18 | 100% | |
FQ2 2001 (Jun 2001) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $1.86B | $1861M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.83B | $1826M | 100% |
FQ1 2019 (Mar 2019) | $0B | $0.92B | $922M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.73B | $1730M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.6B | $1601M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.76B | $1759M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.78B | $1784M | 100% |
FQ2 2001 (Jun 2001) | $0B | $1.15B | $1146M | 100% |